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Summary
The small GTPase Rab11 regulates the recycling of
endosomes to the plasma membrane via interactions
with the Rab11 family of interacting proteins (FIPs).
FIPs contain a highly conserved Rab binding domain
(RBD) at their C termini whose structure is unknown.
Here, we have determined the crystal structure of the
RBD of FIP2 in complex with Rab11(GTP) by single
wavelength anomalous diffraction methods. The over-
all structure is a heterotetramer with dyad symmetry,
arranged as a Rab11-(FIP2)2-Rab11 complex. FIP2
forms a central a-helical coiled coil, with both helices
contributing to the Rab11 binding patch on equivalent
and opposite sides of the homodimer. Switch 1 of
Rab11 is embedded between the two helices, while
switch 2 remains flexible and is peripherally associ-
ated with the effector. The complex reveals the struc-
tural basis for Rab11 recognition by FIPs and suggests
themolecular mechanisms underlying endocytic recy-
cling pathways.
Introduction
The Rab family of small GTPases, which contains nearly
70 proteins, constitutes the largest member of the Ras
superfamily (Bock et al., 2001; Pfeffer, 2005). Rabs are
anchored to lipid bilayers via C-terminal prenylation
sites at cysteine residues, and they regulate various as-
pects of membrane dynamics, including organelle struc-
ture, vesicle motility, docking, and fusion (Zerial and
McBride, 2001). The Rab11 subfamily comprises three
isoforms—Rab11a, Rab11b, and Rab25. Rab11a and
Rab11b are found in most tissue (Goldenring et al.,
1996; Lapierre et al., 2003), while Rab25 expression is
*Correspondence: amirrafk@tcd.ierestricted to epithelial cells (Goldenring et al., 1993).
The Rab11 proteins regulate the endosomal recycling
transport of vesicular cargo containing transferrin recep-
tors (Ullrich et al., 1996; Wilcke et al., 2000; Prekeris et al.,
2000; Lindsay and McCaffrey, 2002), the chemokine
receptor CXCR2 (Fan et al., 2004), and polymeric IgA
receptors (Wang et al., 2000). More recently, Rab25 has
been shown to determine the aggressiveness of breast
and ovarian cancers, and its expression has been linked
to tumorigenesis (Cheng et al., 2004, 2006).
The biological effects of Rabs are elicited by their GTP
bound conformation through interactions with effector
proteins. The structures of Rabs have a common G pro-
tein fold with a central six-stranded (mixed) b sheet
flanked by a helices on both sides. The nucleotide state
of Rabs affects the local conformation of a pair of highly
conserved regions termed switch 1 and switch 2 (Vetter
and Wittinghofer, 2001). The crystal structures of Rab3-
rabphilin, Rab4-rabenosyn5,Rab5-rabaptin5,Rab7-RILP,
and Rab22-rabenosyn5 have been determined (Oster-
meier and Brunger, 1999; Zhu et al., 2004; Wu et al.,
2005a; Eathiraj et al., 2005), and both switch 1 and switch
2 have well-defined electron density in these structures.
Switch 1 and/or switch 2 contribute to interactions with
the Rab binding domain (RBD) of effectors, which are
generally a-helical in conformation (Kawasaki et al.,
2005). However, the orientation of the helices, the oligo-
meric states of effectors, and detailed interactions with
Rabs are unique in all of these complexes. An emerging
theme in Rab recognition is the exploitation of noncon-
served residues combined with structural diversity in
conserved regions (switch 1, switch 2, interswitch) to
achieve selective Rab binding by effectors (Pfeffer,
2005; Eathiraj et al., 2005; Merithew et al., 2001).
In recent years, a novel set of effectors termed the
Rab11 family of interacting proteins (hereafter abbrevi-
ated as FIPs) that contain a highly conserved C-terminal
RBD has been identified (Prekeris et al., 2000, 2001;
Hales et al., 2001; Lindsay and McCaffrey, 2004b; Lind-
say et al., 2002). In contrast to their RBDs, FIPs are di-
verse in sequence length and composition toward their
N termini, presumably a feature that underpins their spe-
cific roles in Rab11-mediated vesicle trafficking. Rip11,
FIP2, and RCP all contain C2 domains toward their N
termini and are categorized as class I FIPs. They are pre-
dominantly localized to the endocytic recycling com-
partment (ERC), and their C2 domains have recently
been observed to participate in this localization through
interactions with lipid bilayers enriched in anionic phos-
pholipids (Lindsay and McCaffrey, 2004a). The class II
FIPs, FIP3 and FIP4, possess an ERM (ezrin-radixin-
moesin) domain, EF hands, and a proline-rich region,
and they are found in the ERC, the trans-Golgi network,
and centrosomes. Class II proteins interact with ADP ri-
bosylation factor (ARF) GTPases (Hickson et al., 2003),
allowing for potential crosstalk between the two signal-
ing pathways. Recent studies identified a role for FIP3
and FIP4 in endosomal trafficking to the cleavage furrow
during cytokinesis via interactions with Rab11 and Arf6
(Horgan et al., 2004; Fielding et al., 2005). FIP1 lacks
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ther the class I nor the class II family (Wallace et al.,
2002; Hales et al., 2001).
Here, we have determined the structure of Rab11 with
the RBD of FIP2 in two different crystal forms. FIP2 is a
512 residue protein that contains a C2 domain at the N
terminus (residues 1–129), a myosin Vb binding region
(129–290), and an RBD at the C terminus (477–496),
previously predicted to form an amphipathic a helix
(Wallace et al., 2002; Lindsay and McCaffrey, 2004b;
Junutula et al., 2004; Meyers and Prekeris, 2002). FIP2
protein has been found to be essential for the recycling
of vesicles bearing the chemokine receptor CXCR2 back
to the plasma membrane (Fan et al., 2004). A ternary
complex of Rab11-FIP2-myosin Vb may provide the
link between endosomes and the cytoskeleton to regu-
late the delivery of vesicular cargo to the plasma mem-
brane. This interaction would form the molecular basis
for recruitment of leukocytes to the site of inflammation.
The crystal structure of the Rab11-FIP2 complex reveals
that both a helices of the central helical dimer of FIP2
contribute to the Rab11 binding patch, thus forming a
2-fold symmetric Rab11-(FIP2)2-Rab11 complex. Switch
1 is embedded between the two a helices of FIP2, while
switch 2 retains significant flexibility and reveals unprec-
edented conformational changes from its unbound
(GTP) conformation, as well as between the two crystal
forms in the Rab11-FIP2 complex. At the C-terminal
half of the RBD, the a helix terminates and the polypep-
tide adopts a 310 helix and a short b strand conformation
that is perpendicular to the ahelix and that packs against
b2 of Rab11. Finally, in a trigonal crystal form, the a-heli-
cal portion of the RBD is extended 20 residues further
in the N-terminal direction relative to orthorhombic
crystals. The conformational heterogeneity observed in
Rab11 and FIP2 likely reflects the dynamic nature of
Rab-effector association in cells, and it provides insight
into the molecular basis for endosomal trafficking
pathways.
Results and Discussion
Overview of Rab11-FIP2 Crystals
Rab11a (1–173) and FIP2 (410–512) were coexpressed
in E. coli and purified as a complex. Rab11 contained
the Q70L substitution to favor the GTP form, and the
subsequent structure revealed that endogenous GTP
had been incorporated during expression and purifica-
tion. Light scattering coupled with gel filtration showed
that FIP2 alone was dimeric (Figure S1; see the Supple-
mental Data available with this article online), and the
mass of the Rab11-FIP2 complex was consistent with
two molecules of Rab11 and two molecules of FIP2
(Jagoe et al., 2006). Crystals of the complex appeared
in orthorhombic and trigonal forms under similar growth
conditions and had related cell parameters (Table 1).
The overall complex is organized as a Rab11-(FIP2)2-
Rab11 oligomer in both crystals, and the centrally lo-
cated FIP2 in the crystals is a parallel, helical coiled coil
that recruits Rab11 on both sides in a symmetric fashion
(Figure 1). In the trigonal space group P3121, the two
molecules of FIP2 and Rab11 are related by the crystal-
lographic dyad that runs down the central axis of the
coiled-coil; thus, the asymmetric unit consists of oneRab11 and one FIP2 molecule. In the P212121 space
group, the symmetry is broken and the helical axis be-
comes a noncrystallographic dyad (180.0) that lies 4
away from the crystallographic c axis. Thus, the asym-
metric unit consists of two molecules each of Rab11
and FIP2 in the orthorhombic space group. The amino
acid segments of Rab11 and FIP2 included in the refined
models are indicated in Table 1. Since a significant por-
tion of the expressed FIP2 polypeptide (410–446 in trigo-
nal; 410–468 in orthorhombic) was not seen in electron
density maps (see Experimental Procedures), we per-
formed N-terminal amino acid sequencing of dissolved
crystals to confirm that these regions were indeed pres-
ent and not proteolyzed during purification and crystalli-
zation (data not shown).
As the complex has 2-fold symmetry, subsequent
descriptions of the structure will address one of the pro-
tomers of Rab11 and its interface with the FIP2 homo-
dimer. Where necessary, the FIP2 protomers will be dis-
tinguished by using the superscript suffixes ‘‘d’’ and ‘‘e,’’
bearing in mind that the chains are related by a 2-fold
axis. Discussions of the structure of Rab11-FIP2 will
be confined mainly to the trigonal model since the qual-
ity of data was superior. However, the orthorhombic
Table 1. Data Collection and Refinement Statistics
Orthorhombic Trigonal
Space group P212121 P3121
Cell dimensions (A˚) 64.4, 91.1, 113.1 64.7, 64.7, 112.4
Wavelength (A˚, Se peak) 0.97865 0.98175
Resolution (A˚) 50–2.44 50–2.47
Completeness (%) 99.7 (98.5) 99.8 (100)
Rmerge (%) 10.2 (42.1) 6.7 (29.7)
I/s(I) all data 8.8 16.3 (15.9)
I/s(I) > 3 (% of data) 51.5 66.3
Redundancy 13 (10) 16 (10)
Refinement Statistics
Resolution (A˚) 50–2.44 50–2.47
Number of reflections 25,444 10,206
Models Rab11
(Glu7–Tyr173)
Rab11
(Asp6–Tyr173)
FIP2
(Arg468–Pro502)
FIP2
(Gly447–Ser503)
FIP2
(Leu466–Pro502)
Rwork/Rfree (%) 22.6/27.9 19.6/25.3
High-resolution shell (27.4/29.7) (22.2/33.0)
Number of nonhydrogen
atoms
3,407 2,011
Number of proteins 3,300 1827
Number of GTP, ions
solute
34 39
Number of waters 78 155
Average B factor (A˚2)
Protein 39.2 47.6
Backbone 38.6 43.9
Side chain 40.2 47.1
GTP 34.6 36.5
Mg2+ 29.3 36.3
Water 38.2 51.9
Rms deviations
Bond lengths (A˚) 0.012 0.016
Bond angles () 1.35 1.83
Coordinate error (ESU)
Based on Rfree 0.27 A˚ 0.30 A˚
Values in parentheses correspond to the statistics for the highest-
resolution shell; orthorhombic = 2.53–2.44 A˚, trigonal = 2.56–2.47 A˚.
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asymmetric unit allows an opportunity to analyze con-
formational changes that may be relevant to function,
and these differences will be discussed.
Structure of the FIP2 Homodimer
The structure of FIP2 in trigonal crystals reveals a 40
residue, gently curving a helix from residue Thr452 to
residue Thr492, followed by a turn, a 310 helix, a short
b strand, and a loop—a shape that resembles the letter
Figure 1. Ribbon Model of the Rab11-FIP2 Complex
(Top) Rab11 molecules are yellow and magenta, while FIP2 is col-
ored dark pink and green. Switch 1 and switch 2 are indicated,
GTP is represented as a stick model, and the conserved Mg2+ ion
is drawn as a sphere. The short 310 helix at the C terminus of FIP2
(green) is also labeled. (Bottom) View of Rab11-FIP2 rotated 90 in
order to show the 2-fold b axis in the crystal. The N and C termini
of each FIP2 molecule hug their symmetrically oriented partner.‘‘L’’ (Figures 1 and 2). The parallel dimer of FIP2 is formed
by the crystallographic 2-fold axis, and the interface
consists mainly of hydrophobic residues that are under-
lined in Figure 3. The side chain of Glu455 (conserved
in all FIPs) hydrogen bonds with the backbone NH of
Thr452, thus capping the first turn of the a helix. The hy-
droxyl group of Tyr453 hydrogen bonds to the carbonyl
oxygen ofLeu451, and itsphenyl ring forms the lid ofahy-
drophobic pocket together with Val456, one turn down
the helical axis. In orthorhombic crystals, this region of
the FIP2 is disordered and is not seen in electron density
maps, and the model begins at Arg468. However, given
that the helix-capping residues from Thr452–Glu455
are highly conserved in FIPs (Figure 3), it is likely that
an elongated a helix plays a structural role in recycling
pathways under cellular conditions. In support of our
view, trigonal crystals grew in lower salt conditions
(100 mM (NH4)3PO4), while higher salt levels (500 mM)
favored orthorhombic crystals. Several interactions in-
volving ionizable side chains are present in this region,
Figure 2. Stereoview of the Electron Density around a Section of the
Rab11-FIP2 Interface in the Orthorhombic Space Group
The 2Fo 2 Fc map is contoured at 1.3 times the rms density. The g-
phosphate of GTP is labeled, Mg2+ is a blue sphere, waters are red,
and hydrogen bonds are indicated by dashed lines. The Rab binding
interface is formed by residues from both a helices of the FIP2 ho-
modimer (‘‘d’’ and ‘‘e’’ suffixes in superscript notation).Figure 3. Sequence Alignment of FIPs and
the Corresponding Secondary Structure
Elements
The long a helix and the short 310 helix are
represented as cylinders, and the short seg-
ment that forms parallel b sheet-like hydro-
gen bonds with b2 of Rab11 is represented
by the arrow. The gray mask represents the
extent of the RBD from the crystal structure.
Asterisks highlight those residues that are
unique in FIP2 and are therefore candidates
for homodimer specificity. Underlined amino
acids correspond to the dimer interface,
and the numbering below the alignments
corresponds to the sequence of FIP2.
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tration (Table S1). The total surface area buried by the
FIP2 dimer in trigonal crystals is 3620 A˚2, and this de-
creases to 1945 A˚2 in the orthorhombic structure. Circu-
lar dichroism (CD) spectroscopy of truncated molecules
is also consistent with the trigonal FIP2 model in solution.
Constructs beginning at Gln458 were poorly structured,
while constructs beginning at Asp443 and Ser450 re-
stored an a helix conformation (Wei et al., 2006). More-
over, limited proteolysis of FIP2(Asp443–Ser512) by
trypsin resulted in cleavage after Arg449 and Arg497.
This segment corresponds exactly to the secondary
structure elements in trigonal crystals (Figure 3). Al-
Figure 4. Rab Binding Interfaces in the Complex
(A) Switch 1 (yellow) interacts with both helices of FIP2 (green and
dark pink) at the ‘‘YID’’ consensus sequence.
(B) The 310 helix and the extended region of FIP2 (green) align with b2
of Rab11. The side chain of Tyr500 is unique to FIP2 and is sand-
wiched between Arg487 and Pro502. The backbone amide nitrogen
of Val46 (switch 1) is within 3.6 A˚ of Tyr480(OH) and is represented by
a blue sphere. A role for the three prolines (Pro493, Pro499, and
Pro502) in stabilizing the conformation of FIP2 in this region is
apparent in this view.though Arg497–Pro502 is also well ordered (see below),
it is located in a loop region (Figure 4B) and is therefore
susceptible to cleavage by trypsin.
The C-terminal region of FIP2 is identical in both crys-
tals and comprises the RBD, which runs from Glu476
to Val498 (Figure 4). The a helix terminates at a proline
(Pro493d), which is conserved in all FIPs and which nu-
cleates a 310 helix (roughly perpendicular to the a helix)
and a loop that forms brief parallel b sheet-like interac-
tions with b2 of Rab11 (see below). At this point, a sec-
ond proline (Pro499d) in the cis configuration reverses
the polypeptide direction to orient the C terminus to-
ward the second protomer and reinforce homodimer in-
teractions. Pro499d is conserved only in class I FIPs and
FIP1 (Figure 3), while the next residue (Tyr500d) is unique
to FIP2 and contributes to the FIP2 dimer interface via a
side chain hydrogen bond to Glu491e. In addition, the
phenyl ring of Tyr500d lies below the guanidino group
of Arg487e, suggesting cation-p interactions, while the
opposite face of the ring stacks against Pro502d
(Figure 4B).
Structure of the Rab11-FIP2 Complex
The 23 residue RBD of FIP2 (Glu476–Val498) at the C-ter-
minal half of the coiled coil is the most conserved in the
FIP family, and it had previously been predicted to form
a continuous amphipathic a helix (Lindsay and McCaf-
frey, 2004b; Junutula et al., 2004; Meyers and Prekeris,
2002). However, the crystal structure of the RBD reveals
an a helix followed by a 310 helix and a b strand, roughly
perpendicular to the a helical axis, that mediates both
dimer formation and interactions with Rab11 (Figures
1–4). The Rab11 molecules do not interact with each
other, consistent with a monomeric form of Rab11(GTP)
(Pasqualato et al., 2004). The structure of the complex
reveals that the binding interface is formed by both pro-
tomers in FIP2, which interact with switch 1 and switch 2,
as well as b2 of Rab11. Switch 1 (Ile44–Val46) is buried
between the two helices of FIP2, packing against
Leu477d, Tyr480d, and Ile481d. In addition to packing,
the phenolic side chain of Tyr480d makes a hydrogen
bond with the backbone of Val46(N). Ile481 is within
van der Waals distance of Gly45 (Ca), and it is also in-
volved in intimate contacts at the homodimeric interface
of FIP2 that bridge the two Rab11 molecules (Figure 4). In
the overall Rab11-(FIP2)2-Rab11 heterotetramer, Tyr480
and Ile481 form an extended hydrophobic surface that
is essential to stabilization of the complex (see mutagen-
esis studies, below).
Interactions between Rab11 and FIP2 in the C-terminal
part of the RBD (after Leu485) are confined to one of the
two protomers in the FIP2 homodimer (Figure 4B).
Met489d, which is substituted by selenomethionine in
the structure, is a key residue at the interface of FIP2
and Rab11 and is conserved in all FIPs except FIP4
(Leu). The side chain of Met489d resides in a hydrophobic
pocket formed by Val46 (switch 1), Trp65, Ile76, and
Ala79, and the latter two residues are localized to the he-
lical part of switch 2. As previously mentioned, Pro493d
terminates the a helix and nucleates a single-turn 310 he-
lix (Figure 4) that packs against the a helix, forming a
hydrophobic pocket involving Val488d, Ile495d, and
Leu496d. This pocket extends into the FIP2 dimeric inter-
face, and Leu496d (from the 310 helix) also packs against
Structure of Rab11-FIP2
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perpendicular to the central b sheet of Rab11 (Figure 4B),
and two backbone hydrogen bonds take place between
residues Leu496d/Val498d of FIP2 and b2 of Rab11
(Phe48). In addition, there are hydrogen bonds between
the side chains of Thr50 and Arg497d in this region
(Figure 4B). The importance of the interactions in this
C-terminal part of the RBD is underscored by recent
studies of the FIP2 construct Ser50–Met489, which ter-
minates before the 310 helix. Despite maintaining the
structural integrity of the a-helical coiled coil, this trun-
cated FIP2 fragment showed no appreciable association
with Rab11, as measured by isothermal titration calorim-
etry (Wei et al., 2006).
Structural Basis for Rab11 Specificity
The molecular basis for specificity of the FIP2 dimer for
Rab11 is clarified by the structure of the complex (Fig-
ure 5). The conformation of switch 2 is unique among
mammalian members of the Rab family with known
three-dimensional structures. In the complex, switch 2
has moved away from switch 1 and toward a3, thus
allowing an intimate complex to form between switch 1
and the FIP2 helices. The flexibility of switch 2 and its
lack of helical content was evident in the Rab11(GTP)
structure, and Cherfils and colleagues suggested that
one possible reason for this is the paucity of switch 1-
switch 2 interactions in the GTP form (Pasqualato
et al., 2004). Upon molecular modeling of other Rabs in
complex with FIP2, we have observed that switch 2 un-
dergoes steric repulsions with the FIP2 helix within the
region of F475–D482 (Figure 5). One key example is
Figure 5. Structural Basis for Rab11 Specificity Encoded by the
Switch 2 Conformation
The structures of Rabs in their GTP and effector bound conformation
were superimposed onto Rab11-FIP2. The coordinates were taken
from files 1ZBD, 1Z0K, 1TU3, and 1YHN in the Protein Data Bank.
A distinctly nonhelical conformation of switch 2 (Sw2, yellow), posi-
tioned toward a3, is observed in Rab11. The position of switch 1
(Sw1) is also shown. The salt bridge between Arg74 and Asp482 is
shown with dashes.Arg74, which is mostly conserved in Rabs and makes
a salt bridge with Asp482 of FIP2. However, the confor-
mations of switch 2 in most other Rabs place the guani-
dino group of this residue in steric conflict with the effec-
tor. Thus, apart from Rab11, the conformations of switch
2 in the GTP state of mammalian Rabs are incompatible
with binding to FIP2. Subtle changes in the conforma-
tion and position of recognition elements within con-
served features of Rabs (such as the switches) have
previously been identified as positive and negative
determinants of specificity (Eathiraj et al., 2005; Meri-
thew et al., 2001).
In addition to switch 2, specificity may also be im-
parted by Lys41 (switch 1; salt bridge to Glu476) and
Thr50 (hydrogen bonds to Arg497). Upon alignment,
threonine is partly conserved in Rab sequences, but
only Rab11 and Rab7 have both of these residues. How-
ever, the conformation of switch 1 in Rab7 is subtly dif-
ferent due to the presence of a tyrosine (Tyr37 in Rab7
numbering) in place of Ser40 in Rab11. In order to avoid
steric clashes with the nucleotide, a backbone rotation
at Tyr37–Lys38 (Rab7) results in the shift of the lysine
side chain 90 away from the equivalent Lys41 in Rab11.
Comparisons with Unbound Rab11(GTP)
and Rab11(GDP)
The structure of Rab11-FIP2 reveals unprecedented
conformational changes in switch 2 of Rab11(GTP) be-
tween the unbound and FIP2 bound forms (Figure 6). Af-
ter least-squares superposition, the greatest difference
occurs at Tyr73, whose side chain hydroxyls reside
19 A˚ apart. The difference is attributable to a rearrange-
ment of the loop Leu70–Ser78, placing this region closer
to a3. This conformational change is necessary for bind-
ing to FIP2, otherwise residues Tyr73–Arg74 would
sterically overlap with the FIP2 helix (Arg475–Asp479).
When comparing the conformation of Rab11(GDP)
alongside Rab11(GTP) and Rab11(GTP)-FIP2, switch 2
follows a distinct trajectory toward a3. The result is
that much of the switch 2 region in the Rab11-FIP2
complex remains free and exposed on either side of
the symmetric dimer.
It should be emphasized that in both trigonal and or-
thorhombic crystals, switch 2 is relatively disordered
after Gly69. This glycine precedes the (presumed) cata-
lytic asparagine, and it makes a hydrogen bond through
its backbone amide to the g-phosphate. Conformational
heterogeneity was apparent when comparing the two
crystal forms, as well as the two molecules within the
asymmetric unit of the orthorhombic crystal form (Fig-
ure 6B). However, switch 2 is clearly displaced toward
a3 in all models of the Rab11-FIP2 complex. Overall,
these observations suggest that switch 2 retains consid-
erable flexibility in the GTP bound form, which is thus far
unique among known structures of Rab-effector com-
plexes. All other Rabs display minor conformational
changes of their side chains and backbones in order to
accommodate effector binding, and these binding reac-
tions can essentially be considered as rigid docks of
preformed switch and interswitch regions.
The conformation and position of switch 1 in Rab11-
FIP2 also differs from those in unbound Rab11(GTP), al-
though in a more subtle manner. The Ser40 position
shifts toward GTP, and the side chain forms a hydrogen
Structure
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be influenced by the adjacent salt-bridged interaction
between Lys41 and Glu476. The side chain of Ser42
(switch 1) rotates to make a hydrogen bond with the g-
phosphate oxygen, and, together, these interactions re-
sult in a more intimate association of switch 1 with the
nucleotide in the FIP2 bound form of Rab11. Finally,
a third serine residue (Ser20) undergoes a side chain ro-
tation to make a hydrogen bond with the same g-phos-
Figure 6. Conformational Changes in the GTP/GDP Cycle of Rab11
(A) The structure of Rab11(GDP) is pink, Rab11(GTPgS) is blue, and
Rab11(GTP) bound to FIP2 is yellow. The PDB codes for Rab11 in
complex with GDP and GTP are 1OIV and 1OIW, respectively. The
structure of Rab11(GppNHp), PDB code 1YZK (not shown), is similar
to that of Rab11(GTPgS).
(B) Conformational flexibility of switch 2 in the Rab11-FIP2 complex.
The reference structure is Rab11-FIP2 in trigonal crystals (green).
The two molecules of Rab11 in the asymmetric unit of orthorhombic
crystals (ortho_A, ortho_B) were superposed onto the structure.
Only the switch regions and the phosphate arm of GTP are shown
for clarity. Magnesium ions are represented as spheres.phate oxygen as Ser42. Overall, the three serine resi-
dues that were pointing away from Rab11(GTP) are
found to be involved in hydrogen bonds with the nucle-
otide in the Rab11-FIP2 complex (Figure 6A).
The preference for Rab11(GTP) relative to the GDP
form is imparted by both switch 1 and switch 2. As dis-
cussed above, the conformation of switch 2 in the GDP
form is incompatible with binding to FIP2 because of
steric overlap (Figure 6). There are also significant back-
bone conformational changes in residues K41–V46,
which favor the close packing of switch 1 between the
FIP2 a helices. In particular, Ile44 of switch 1 plays a crit-
ical packing role in the complex, but in its GDP state, the
position and conformation of switch 1 would place the
side chain of Ile44 in steric conflict with the ring of
Tyr480 (not shown). The equilibrium dissociation con-
stant (Kd) of FIP2 with Rab11(GDP) is 1.3 mM, and it is
lowered over 30-fold (40 nM) with the GTP form of
Rab11 (Junutula et al., 2004). Interestingly, the recent
crystal structure of Rab11b(GDP), which is 90% identi-
cal to the Rab11a isoform, revealed a 310-helical confor-
mation in the segment Gly69–Tyr73 (Scapin et al., 2006).
The helix disappeared in active Rab11b(GTP), with
switch 2 adopting a conformation identical to that of
Rab11a(GTP). Overall, these findings correlate with
solution studies of the two GTP bound isoforms that re-
vealed similar binding affinities for FIP2 (Kd = 40–44 nM)
and are consistent with an unusually flexible conforma-
tion for switch 2 in Rab11.
Comparisons to Other Rab-Effector Complexes
The crystal structures of four effectors with their cog-
nate Rabs have been determined previously (Rab3-rab-
philin, [Ostermeier and Brunger, 1999]; Rab5-rabaptin5,
[Zhu et al., 2004]; Rab7-RILP, [Wu et al., 2005a]; Rab4-
rabenosyn5 and Rab22-rabenosyn5, [Eathiraj et al.,
2005]). The structure described here resembles that of
Rab5-rabaptin5 and Rab7-RILP in its overall organiza-
tion as a dyad symmetric complex, in which a coiled-
coil effector domain brings together two independent
Rab molecules on either side. However, the Rab5-
rabaptin5 interaction occurs mainly through switch 2 and
interswitch regions. Also, the central axis of the rabap-
tin5 coiled coil lies parallel to b2 of Rab5, whereas the
central axis in Rab11-FIP2 is offset by 70 relative to
this orientation. In contrast to FIP2 and rabaptin5, the ef-
fector RILP is a four-helix bundle that binds extensively
to segments of Rab7 that are distant from the switch and
interswitch regions (Wu et al., 2005a).
In summary, a-helical motifs constitute the RBDs in all
Rab-effector complexes determined to date, and the in-
terface generally consists of hydrophobic interactions.
The central recognition elements are switch 1 and switch
2, but effector proteins vary with respect to the position
and orientation of their a helices on the surface of
Rabs. Interestingly, a single a helix is insufficient to con-
stitute a complete Rab binding interface in these com-
plexes. FIP2, rabaptin5, and RILP are all dimers, while
the monomeric RBD of rabenosyn5 consists of a helical
hairpin. Rabphilin contains a second interface mediated
by a zinc-containing globular domain, in addition to the
single long a helix that interacts with switch 1 and switch
2 (for a review, see Kawasaki et al., 2005).
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Localization of FIP2 Mutants
The crystal structure of Rab11-FIP2 suggested that
Tyr480 and Ile481 play an essential role in forming the
interface with Rab11. Therefore, we performed site-
directed mutagenesis to substitute Tyr480 with phenyl-
alanine (Y480F) and the isoleucine at position 481 to
glutamate (I481E). The effect of these amino acid substi-
tutions on the subcellular localization of FIP2 was
assessed. We used the yeast two-hybrid system to ex-
amine the ability of these mutants to bind Rab11 and
their ability to homodimerize. The nonconservative
I481E mutation abolished the interaction with Rab11,
while the Y480F mutation had little effect on Rab11 bind-
ing, as evidenced by the ability of yeast colonies to grow
on reporter media lacking histidine (Figure 7A; see Ex-
perimental Procedures). Consistent with previous stud-
ies on Rip11, neither of the FIP2 mutants affected dimer-
ization (Figure 7B) (Junutula et al., 2004). To determine
the effect of these mutations on the subcellular localiza-
tion of FIP2, the wild-type and mutant proteins were
expressed as green fluorescent protein (GFP) fusions
in HeLa cells. Western blot analysis confirmed that
the mutant proteins expressed well in these cells and
migrated at the same molecular weight as wild-type
FIP2 (Figure 7C). Upon examination by confocal micros-
copy, GFP-FIP2 displayed a punctate vesicular pattern,
whereas both mutants were predominantly cytosolic
and had some plasma membrane labeling (Figure 7D).
The observed plasma membrane localization of the
FIP2 mutants is likely to be mediated by the C2 domain
of FIP2, and, indeed, we observed some colocalization
between the mutants and an antibody that labels
PI(3,4,5)P3 (data not shown).
These cellular assays demonstrate the exquisite sen-
sitivity of the Tyr480/Ile481 locus and its critical role in
vesicular localization of FIP2. The cytosolic distribution
of FIP2 mutants is similar to the phenotype seen in the
equivalent Rip11 mutants Y628F and I629E (Junutula
et al., 2004). Despite the conservative nature of the
Y480F substitution, a hydrogen bond between the phe-
nolic oxygen and the backbone of Val46(N) would be
eliminated from each of the two Rab11-RBD interfaces
(Figure 2). Although this mutant can interact with Rab11
in vitro, as judged by yeast two-hydrid assays, the pre-
sumed decrease in affinity manifests itself under cellular
conditions as a phenotype that resembles mutants that
do not interact with Rab11 (Figure 7D). The correspond-
ing mutation in Rip11(Y628F) resulted in an increase in
Kd from 40 nM to 530 nM (Junutula et al., 2004). The
yeast two-hybrid assays show that the FIP2(I481E) mu-
tant fails to interact detectably, consistent with isother-
mal titration calorimetry (ITC) studies of the Rip11(I629E)
mutation (Junutula et al., 2004). The structure of Rab11-
FIP2 reveals the molecular basis for the severity of this
mutation. Upon modeling of the I481E mutant (data not
shown), the glutamate side chain would interfere with
the hydrophobic interface between Tyr480 and Ile44 in
switch 1 (Figure 4).
Rab11-FIP2 and Vesicle Trafficking
Structural and biophysical studies support a model for
endosomal recruitment of FIP2 in which Rab11(GTP)
molecules bind to preformed FIP2 homodimers. Lightscattering coupled to gel filtration and circular dichroism
(CD) spectroscopy studies of our FIP2 construct
(Ala410–Ser512; Figures S1 and S2) in solution have
confirmed that the molecule is an a-helical dimer. Our
CD spectrum is similar to published spectra from vari-
ous constructs (Junutula et al., 2004; Wei et al., 2006)
that encompass the entire ordered segment of FIP2
that we observe in trigonal crystals. Upon stable
Figure 7. Effect of Mutations on FIP2 Dimerization, Binding to
Rab11, and Cellular Localization
(A) Yeast two-hybrid analysis of the FIP2 mutants. GAL4 activation
domain (AD) fusion constructs of FIP2 (wild-type and mutants)
were cotransformed with GAL4 binding domain (BD) fusions of
Rab11 into the L40 strain of S. cerevisiae. Transformant colonies
were spotted onto media containing histidine (His+) as a control or
media lacking histidine (His2). An interaction is indicated by growth
on His2 media.
(B) GAL4 activation domain fusion constructs of FIP2 were cotrans-
formed into the L40 strain of S. cerevisiae with GAL4 binding domain
fusions of FIP2. Transformant colonies were spotted onto media that
containing histidine (His+) as a control or media lacking histidine
(His2). An interaction is indicated by growth on His2 media.
(C) FIP2 wild-type and mutant proteins are expressed in HeLa cells
and migrate at the same molecular weight. Lysates of HeLa cells ex-
pressing GFP-FIP2, GFP-FIP2(Y480F), and GFP-FIP2(I481E) were
separated by SDS-PAGE, transferred to nitrocellulose, and probed
with anti-GFP.
(D) The FIP2 mutants are predominantly cytosolic. HeLa cells trans-
fected with the indicated construct were fixed and analyzed by con-
focal microscopy.
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plex
Switches 1 and 2 are colored red and blue,
respectively, and GTP is shown in cyan. The
model reveals the approximate orientation
of the complex with respect to the membrane
plane. The last 35 amino acids of Rab11 lead-
ing to peripheral attachment to the lipid bila-
yer are shown as dotted lines. In the ‘‘top
view,’’ looking down the 2-fold axis, switch
2 is available on each side for possible inter-
actions with effectors. The slow/indirect
endocytic recycling mutation S29F31 is local-
ized to the opposite side of Rab11, adjacent
to switch 1. The segment of FIP2 from
Gly447 to Leu467 is shown in a ribbon model
to allow unobstructed views of potential ef-
fector binding sites in the lower panel.formation of Rab11-(FIP2)2-Rab11, the N terminus of
FIP2 would be oriented away from the Rab11-anchored
membrane (Figures 8 and 9). The existence of hetero-
dimers of FIPs in vivo has been suggested, raising the
possibility of crosstalk between FIP signaling pathways
(Wallace et al., 2002; Junutula et al., 2004). However,
only homodimers of FIPs are detected in vitro (Junutula
et al., 2004; Ducharme et al., 2005) despite the high de-
gree of sequence and (presumably) structural conserva-
tion in the RBD. An analysis of the structure suggests
that dyad-symmetric homodimers may be favored in
terms of affinity over heterodimers by the composition
of residues flanking the RBD (asterisks in Figure 3).
Figure 9. N-Terminal Segment of FIP2, Distal to the Rab Binding
Interface
Tyr453 forms a lid over the coiled coil, which is stabilized mainly
through hydrophobic contacts. However, several salt bridges and
hydrogen bonds also stabilize the homodimer.The eps15 homology domain (EHD) proteins EHD1
and EHD3 bind to FIP2 via a series of ‘‘NPF’’ motifs (Nas-
lavsky et al., 2006), the last of which is located 40 resi-
dues upstream (Asn407–Phe409) of the present model
of FIP2. Extension of the RBD a helix by an additional
24 residues in the N-terminal direction may play a struc-
tural role in the recruitment process by modulating the
position and orientation of the binding regions. Further
toward the N terminus resides the myosin Vb tail binding
region of FIP2 (Arg129–Val290) (Hales et al., 2002) and
the C2 phospholipid binding domain (Val15–Ala102)
(Lindsay and McCaffrey, 2004b). Given the orientation
of the Rab11-FIP2 complex (Figure 8), the C2 domain
is more likely directed toward an opposing membrane
surface, although there is sufficient intervening se-
quence (w345 residues) for FIP2 to reverse direction
and interact with the Rab11-anchored membrane. An
opposing membrane orientation of FIP2 is consistent
with our previously proposed model, suggesting that
C2 domains of class I FIPs target recycling vesicles to
the plasma membrane (Lindsay and McCaffrey, 2004a).
In addition to the role it plays in FIPs and endosomal
trafficking, Rab11 is involved in related functions, includ-
ing the organization of membranes for phagocytosis in
macrophages (Cox et al., 2000), regulation of cellular
cholesterol stores (Holtta-Vuori et al., 2002), and, more
recently, targeting of vesicles to budding sites in yeast
(Wu et al., 2005b). For these functions, Rab11 recruits
effectors such as Rabphilin-11 (Zeng et al., 1999) and
Sec15 (Wu et al., 2005b) that are structurally unrelated
to FIPs and that may recognize Rab11 in a distinct man-
ner. Upon mutation of Rab11(Ser29) to phenylalanine
and subsequent trafficking assays, the authors
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recycling pathway relative to previously characterized
mutants of Rab11, suggesting the presence of multiple
effector binding sites (Pasqualato et al., 2004). Intrigu-
ingly, the Ser29 locus lies exposed on equivalent and op-
posite sides of the Rab11-FIP2 complex. In conclusion,
the structure described here provides a platform for fur-
ther interactions with effectors, and it suggests a rational
course for future mutagenesis, structural, and cellular
studies.
Experimental Procedures
Protein Expression and Purification
Primers containing a 50 NcoI site and a 30 EcoRI site were used to
PCR amplify the FIP2 cDNA corresponding to amino acid residues
410–512. Full-length FIP2 in the pTrcHisA plasmid was used as a
template for Taq polymerase (New England Biolabs) PCR amplifica-
tion. Upstream and downstream primers were 50-gcataccatggcagc
aaaattcagggcttcaaat-30 and 50-accggaattcttaactgttagagaatttgccag
ctt-30, respectively. Rab11a cDNA (coding for residues 1–173) was
similarly amplified with flanking Nco1 and EcoR1 restriction sites.
Upstream and downstream primers were 50-aatgccatgggcacccgcga
cgac-gagtacgac-30 and 50-accggaattcttagtatatctctgtcagaattgtct-30,
respectively. The template for PCR was full-length Rab11 in the plas-
mid pTrcHis, and this template contained the Q70L mutation. After
amplification and double digestion by the restriction endonucle-
ases, ligations were carried out with the TaKaRa ligation kit (Cam-
brex Corp.). FIP2 was cloned into the vector pMAL-parallel 2 (a mod-
ification of pMAL-c2x containing an rTEV cleavage site) by using the
NcoI and EcoRI restriction sites and was expressed as a fusion pro-
tein with mannose binding protein (MBP). Rab11 was cloned into the
pET-28b vector without an affinity tag.
The two resulting expression plasmids were cotransformed into
BL21(DE3) cells. Overexpression was carried out in SeMet Media
(Molecular Dimensions) supplemented with 100 mg/ml ampicillin
and 30 mg/ml kanamycin at 37C. Selenomethionine (100 mg/l,
Sigma-Aldrich) was added at the time of induction (OD600 = 0.6,
0.5 mM IPTG), and cells were grown for an additional 3 hr, harvested
by centrifugation, and stored at 220C. Frozen pellets were resus-
pended in MBP extraction buffer (20 mM Tris-HCl, 200 mM NaCl,
5 mM MgCl2, and 10 mM b-mercaptoethanol [pH 7.8]) and sonicated
(2 3 1 min) at room temperature. Cell lysates were centrifuged at
20,000 3 g to remove cell debris, and the resultant supernatant
was applied to an amylose resin (New England Biolabs). After exten-
sive washing with MBP extraction buffer, bound protein was eluted
with MBP elution buffer (extraction buffer supplemented with 10 mM
maltose). Eluted protein was dialyzed overnight against 10 mM Tris
(pH 8.0), 25 mM NaCl in the presence of rTEV protease (20 mg/mg
fusion protein). Cleaved protein was loaded onto an ion-exchange
column (MonoQ GL 5/50, GE Healthcare), and a salt gradient was
applied (10–500 mM NaCl) over a 20-fold excess column volume.
The protein fractions corresponding to the Rab11-FIP2 complex
were pooled and further purified on a superdex 200 16/60 column
(GE Healthcare) equilibrated in column buffer (10 mM Tris-HCl,
100 mM NaCl, 5 mM MgCl2, 1 mM DTT [pH 8.0]). The protein peak
was prepared for crystallization on 10 kDa cutoff concentrators
(Millipore) to a final concentration of 8.25 mg/ml, as measured by
the Bradford dye assay (Bradford, 1976), by using bovine serum
albumin as a standard. The expression and purification of FIP2
(alone) was performed in the same way as described above, but
without Rab11 coexpression.
Crystallization and Structure Determination
Purified Rab11-FIP2 was crystallized by hanging drops in a 1:1 ratio
with reservoir containing 100–400 mM ammonium phosphate (pH
4.5–5.5). Trigonal crystals (P312) typically appeared in lower salt
concentration ranges. Data were collected on beamline BM14
(ESRF, Grenoble) at the Se peak from a single trigonal and ortho-
rhombic crystal and were processed by using the HKL2000 package
(Otwinowski and Minor, 1997). Initial phases were calculated for the
trigonal data set by using a novel likelihood target for single-wave-length anomalous diffraction (SAD) experiments implemented in
PHASER (McCoy et al., 2004), by using all data from 50–2.44 A˚. After
DM, the map was of sufficient quality for automated model building
by ARP-/wARP (Perrakis et al., 1999), as implemented in the CCP4
package (CCP4, 1994). The initial model contained 139 residues of
Rab11 (83% of the final model) and 37 residues of FIP2 (E455-
T492). Structure refinement involved the rebuilding of several loops
(including switch 2) and extension of both polypeptides in the N and
C termini and was performed with COOT (Emsley and Cowtan,
2004); restrained TLS refinement was performed with Refmac5 (Mur-
shudov et al., 1997). The structure of Rab11-FIP2 in the orthorhom-
bic crystal was determined by molecular replacement with the trigo-
nal model. One molecule of Rab11 and one molecule of FIP2 were
used as separate search models in PHASER (McCoy et al., 2005).
The structure was refined with multiple rounds of Refmac5 and
model building in COOT. Medium restraints for the structurally con-
served segments of Rab11 and FIP2 were used throughout refine-
ment. However, map averaging did not improve electron density
maps, and several loop regions of Rab11 (including switch 1 and
switch 2) and the N-terminal region of FIP2 were excluded from
averaging; models were built and refined independently.
Site-Directed Mutagenesis
Site-directed mutagenesis was performed by using the QuikChange
kit (Stratagene) according to the manufacturer’s instructions.
pEGFP-C1 FIP2 (Lindsay and McCaffrey, 2002) was the template,
and the following sense and antisense oligonucleotides were used:
FIP2(Y480F): sense 50-ACATCCGGGAACTCGAGGACTTCATCG
ACAACCTCCTTGTAAG-30
FIP2(Y480F): antisense 50-CTTACAAGGAGGTTGTCGATGAAGT
CCTCGAGTTCCCGGATGT-30
FIP2(I481E): sense 50-CGGGAACTCGAGGACTACGAGGACAAC
CTCCTTGTAAGG-30
FIP2(I481E): antisense 50-CCTTACAAGGAGGTTGTCCTCGATG
TCCTCGAGTTCCCG-30
Incorporation of the mutations was confirmed by sequencing.
FIP2(Y480F) and FIP2(I481E) were digested from pEGFP-C1 with
EcoRI and subcloned into the EcoRI site of the pGADGH yeast
two-hybrid vector. The yeast two-hybrid experiments were per-
formed as previously described (Lindsay and McCaffrey, 2002).
Cell Culture and Fluorescence Microscopy
HeLa cells were maintained in culture in DMEM (BioWhittaker)
supplemented with 10% fetal bovine serum, 100 U/ml penicillin,
100 mg/ml streptomycin, and 2 mM L-glutamine at 37C with 5%
CO2. For fluorescence microscopy, cells were grown on 10 mm
glass coverslips and transfected by using Effectene (Qiagen)
according to the manufacturer’s instructions. Approximately 18 hr
posttransfection, the cells were fixed with 3% paraformaldehyde
and mounted on glass slides with Mowiol. Images were acquired
on a Zeiss LSM 510 confocal microscope by using a PlanApo 633
1.4 NA oil immersion objective.
Supplemental Data
Supplemental Data include light scattering and circular dichroism
studies and are available at http://www.structure.org/cgi/content/
full/14/8/1273/DC1/.
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